期刊文献+

小儿扩张型心肌病预后影响因素 被引量:3

FACTORS THAT INFLUENCE THE PROGNOSIS OF DILATED CARDIOMYOPATHY IN CHILDREN
下载PDF
导出
摘要 目的探讨小儿扩张型心肌病(DCM)预后的影响因素。方法回顾性分析20例DCM病儿的临床资料。结果首次入院时存在心力衰竭者18例(90%),心律失常16例(80%),心源性休克4例(20%)。死亡组(9例)病儿的左心室舒张末期内径(LVDd)及收缩末期内径(LVDs)均大于存活组(11例),左心室射血分数(LVEF)及左心室短轴缩短率(LVFS)均小于存活组,差异均有显著意义(t=2.13~3.25,P<0.05)。死亡组7例存在严重心律失常,存活组仅2例(P=0.028)。Logistic回归单因素分析提示,LVDd、LVDs、LVFS、LVEF及心律失常与预后有关(P=0.014~0.048);多因素分析显示,LVEF是预后的独立预测因素(P=0.018)。结论严重心律失常、低LVEF及LVFS、高LVDd及LVDs提示DCM病儿预后不良,提高LVEF可改善预后。 Objective To study the factors affecting prognosis of dilated cardiomyopathy (DCM) in children. Methods Clinical data of 20 children with DCM were retrospectively reviewed. Results Of the 20 sick children reviewed, 18 (90%) with heart failure at the first admission, 16 (80 %) with arrhythmias, and four (20%) with cardiogenic shock. In death group (9 pa- tients), their left ventricular end diastolic inner diameter (LVDd) and left ventricular end systolic inner diameters (LVDs) were greater than that in survival group (n= 11), and their left ventricular ejection fraction (LVEF) and left ventricular fractional short ening (LVFS) were lower (t=2.37-3.25,P〈0.05). In the death group, seven had serious cardiacarrhythmias, there wereonly two in survival group (P=0. 028). The logistic regression analysis revealed that the related factors with prognosis were LVDd, I.VDs, LVFS, LVEF and arrhythmias (P= 0. 014-0. 048), and multivariate regression analysis indicated that LVEF was an inde- pendent factor related to the prognosis (P=0. 018). Conclusion The presence of severe arrhythmia, low LVEF, LVFS, high LVDd and I.VDs were the predictors for a poor prognosis in children with DCM, raising LVEF can improve their prognosis.
出处 《齐鲁医学杂志》 2012年第4期352-354,357,共4页 Medical Journal of Qilu
关键词 心肌病 扩张型 儿童 预后 因素分析 统计学 cardiomyopathy,dilated child prognosis factor analysis, statistical
  • 相关文献

参考文献11

  • 1MARON B J, TOWBIN J A, THIENE G, et al. Contempo- rary definitions and classifications of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplanta- tion Committee: Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdiscipli nary Working Groups:and Council on Epidemiology and Pre- vention[J]. Circulation, 2006,113(14) :1807-1816.
  • 2LIPSHULTZ S E, SLEEPER L A, TOWBIN J A, et al. The incidence of pediatric cardiomyopathy in two regions of the United States[J]. The New England Journal of Medicine, 2003,348 (17) : 1647-1655.
  • 3DEVEREUX R B, REICHEK N. Echocardiographic determi- nation of left ventricular mass in man. Anatomic validation of the method[J]. Circulation, 1977,55(4) :613-618.
  • 4MATSUMORI A, FURUKAWA Y, HASEGAWA K, et al. Epidemiologic and clinical characteristics of cardiomyopathies in Japan: results from nationwide surveys [J]. Circulation Journal: Official Journal of the Japanese Circulation Society, 2002,66 (4): 323-336.
  • 5GRIFFIN M L, HERNANDEZ A, MARTIN T C, et al. Dilated eardiomyopathy in infants and children[J]. Journal of the American College of Cardiology, 1988,11(1) :139-144.
  • 6王英,曹春林,卢吉春.扩张型心肌病病人心律失常与心功能的关系[J].青岛大学医学院学报,2003,39(4):466-467. 被引量:7
  • 7ALVAREZ J A, WILKINSON J D, LIPSHULTZ S E. Out- come predictors for pediatric dilated cardiomyopathy: a sys- tematic review[J]. Progress in Pediatric Cardiology, 2007,23 (1):25-32.
  • 8AZEVEDO V M, ALBANESI FILHO F M, SANTOS M A, et al. How can the echocardiogram be useful for predicting death in children with idiopathic dilated cardiomyopathy[J]? Arquivos Brasileiros de Cardiologia, 2004,82 (6): 505-514.
  • 9TOWBIN J A, LOWE A M, COLAN S D, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children[J]. JAMA: the Journal of the American Medical Association, 2006,296 (15) : 1867-1876.
  • 10DAUBENEY P E, NUGENT A W, CHONDROS P, et al Clinical features and outcomes of childhood dilated cardiomy opathy: results from a national population-based study [ J] Circulation, 2006,114(24) : 2671-2678.

二级参考文献6

  • 1陈新主编.临床心律失常学[M].北京:人民卫生出版社,2000.1148.
  • 2MERIT-HF Study Group. Effect of metoprolol Cp/XL randomised intervention trial in congestire heart failure[J]. Lancet, 1999,353:2001.
  • 3REGITZ Z V, LEUCHS B, KRULLS M J, et al. Angiotension converting enzyme inhibitors and betablockers in long-term treatment of dilated cardiomyopathy[J]. Am Heart J,1995,129:754.
  • 4KURZ T, OFFINER B, SCHREIECK T, et al. Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat heart, naungn schmiedebergs[J]. Arch Pharmacol, 1995, 352:491.
  • 5BRISTOW M R. Mechanism of action of betablocking agent in heart failure[J]. Am Cardiol J, 1997,80: 26.
  • 6SZABO B M, CRIJMS H, WIEFIELD A, et al. Predicfors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function, importance of B-blokad[J]. Am Heart J , 1995,130:281.

共引文献10

同被引文献23

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部